Bristol-Myers Squibb Adds $3 Billion to Share Repurchase Program and Raises Dividend

Gelonghui December 7 | The board of pharmaceutical company Bristol-Myers Squibb approved an additional $3 billion stock repurchase plan on Thursday, bringing its multi-year repurchase program to $5 billion. The company announced it would increase its quarterly dividend to 60 cents per share. The company also stated that its combination therapy for treating a type of colorectal cancer met the primary endpoint in an interim analysis of a late-stage study.